The DOI matches its Crossref record.
Enhancement of Angiotensinogen Expression in Angiotensin II–Dependent Hypertension
Open accessAbstract
Abstract —Chronic infusion of angiotensin (Ang) II leads to the development of hypertension and enhances intrarenal Ang II content to levels greater than can be explained from the circulating concentrations of the peptide. We previously reported that renal angiotensinogen (Ao) mRNA is enhanced in Ang II–dependent hypertension and may contribute to augmented intrarenal Ang II levels, but the Ao protein levels were not significantly increased. Because a high-salt diet (H/S) has been shown to suppress renal expression of Ao mRNA, we examined the effects of chronic Ang II infusion on kidney and liver Ao mRNA and protein levels in male Sprague-Dawley rats (n=12) maintained on an 8% salt diet. Ang II was administered via osmotic minipumps (40 ng/min) to 1 group (n=6) while the remaining rats were sham-operated. A H/S diet alone did not alter systolic blood pressure in sham animals (109±6 mm Hg at day 12); however, Ang II infusions to the H/S rats significantly increased systolic blood pressure (167±7 at day 12) and intrarenal Ang II content (459±107 fmol/g versus 270±42) despite a marked suppression of plasma renin activity (0.9±0.2 ng Ang I · mL −1 · h −1 versus 2.8±1.3). Ang II infusions significantly increased kidney Ao mRNA compared with the H/S diet alone by 1.9±0.1-fold. Western blot analysis of kidney protein extracts showed that the Ang II–infused rats had increased kidney Ao protein levels compared with the H/S diet alone (1.9±0.1-fold). Liver Ao mRNA and protein and plasma Ao protein were also significantly increased by Ang II infusions. These data demonstrate the effects of Ang II infusion to stimulate Ao mRNA and protein. Thus, the augmented intrarenal Ang II in Ang II–dependent hypertension may result, in part, by a positive amplification mechanism to activate renal expression of Ao.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Kobori, H., Nangaku, M., Navar, L. G., & Nishiyama, A. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.3.3 · Cited by 1,237
Self-citationAngiotensin II revisited: new roles in inflammation, immunology and aging
Benigni, A., Cassis, P., & Remuzzi, G. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000080 · Cited by 757
Carey, R. M., & Siragy, H. M. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0001 · Cited by 603
Regulation of Intrarenal Angiotensin II in Hypertension
Navar, L. G., Harrison-Bernard, L. M., Nishiyama, A., & Kobori, H. (2002) · Hypertension · doi:10.1161/hy0202.103821 · Cited by 375
Self-citationWolf, G., & Ritz, E. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00145.x · Cited by 289
Metadata
- Authors
- Kobori, H., Harrison-Bernard, L. M., & Navar, L. G.
- Venue
- Hypertension
- Published
- 2001-05
- Volume
- 37
- Issue
- 5
- Pages
- 1329-1335
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2143515869
- Cited by
- 183
- References
- 0
- FWCI
- 5.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Enhancement of Angiotensinogen Expression in Angiotensin II–Dependent Hypertension. https://app.cochat.ai/papers/10.1161/01.hyp.37.5.1329
- The paper
- Kobori, H., Harrison-Bernard, L. M., & Navar, L. G. (2001). Enhancement of Angiotensinogen Expression in Angiotensin II–Dependent Hypertension. Hypertension. https://doi.org/10.1161/01.hyp.37.5.1329
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.